Study of AMG 910 in Subjects With CLDN18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT04260191 · TERMINATED
Trial details
- NCT number
- NCT04260191
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-29
- Primary completion
- 2022-06-02
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.